Amilopra

Amilopra appartiene a Pacific-AA Group, con sede in Myanmar (Birmania). No. Il proprietario finale di Amilopra, Pacific-AA Group, ha sede in Myanmar (Birmania), non negli Stati Uniti.

Pacific-AA Group is a leading conglomerate in Myanmar specializing in the manufacturing and distribution of pharmaceuticals, medical equipment, and consumer goods.